6-hydroxy-1,3-dimethyl-4-sulfanylidene-1,2,3,4-tetrahydropyrimidin-2-one, 97%, 500mg

5-Amino-3-(4-fluorophenyl)isoxazole>95.0%(HPLC)(N)1g

3-Benzofurancarboxylic acid, 2-methyl-, methyl ester, 1g

5-(1-methylcyclopropoxy)-2H-indazole, 95%, 250mg

DAPI, min.98%, pour la biochimie, 25 mg, emballage en verre

2-(2-Naphthyl)-2-propanol, 97.0%, 100mg

3-Hydroxy-3-methylbutanoic acid, 97.0%, 500g

2-((2R,3R,4R,5R,6R)-3,4,5-tris(benzyloxy)-6-((benzyloxy)methyl)tetrahydro-2H-pyran-2-yl)acetamide, 98%, 100mg

4-Amino-3-nitropyridine>98.0%(GC)(T)25g

(1-Methylpiperidin-4-yl)methanol, 99.00%, 25g

4-Methoxy-2(1H)-pyridinone, 95.0%, 5g

1-Octadecyl-4-((1E,3E)-4-phenylbuta-1,3-dien-1-yl)pyridin-1-ium bromide, 97%, 1g

3,3,3-Trifluoropropane-1,2-diol, 97%, 5g